Article Details
Retrieved on: 2022-10-11 16:25:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Neumora Therapeutics secured an additional $112 million in a Series B financing round to support the advancement of its neuroscience portfolio.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here